Sichuan, China

Fengtian Du

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fengtian Du: Innovator in Pharmaceutical Synthesis

Introduction

Fengtian Du is a notable inventor based in Sichuan, China. He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of methods for producing complex compounds. His work is characterized by a focus on innovative techniques that enhance industrial production processes.

Latest Patents

Fengtian Du holds a patent for the "Preparation method of 5-[[2(R)-[1(R)-[3,5-bis(trifluoromethyl) phenyl]ethoxy]-3(S)-4-fluorophenyl-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazole-3-one." This patent discloses a synthesis method for a compound known as aprepitant. The method involves cyclizing a specific compound in a solvent, where R is C-Calkyl. This innovative approach is particularly suitable for the industrial production of aprepitant, showcasing Du's expertise in pharmaceutical chemistry.

Career Highlights

Fengtian Du is associated with Chengdu Di'ao Pharmaceutical Group Co., Ltd., where he has been instrumental in advancing research and development initiatives. His work has not only contributed to the company's portfolio but has also positioned it as a leader in the pharmaceutical industry.

Collaborations

Throughout his career, Fengtian Du has collaborated with esteemed colleagues such as Jianxin Ji and Qiang Zhang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Fengtian Du's contributions to pharmaceutical synthesis and his innovative patent for aprepitant exemplify his commitment to advancing the field. His work continues to impact the pharmaceutical industry positively, paving the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…